Arcturus Therapeutics (ARCT) Stock Chart & Stock Price History → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free ARCT Stock Alerts $26.96 -0.25 (-0.92%) (As of 11:51 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media Arcturus Therapeutics Stock Price Performance5 Day Performance-1.14%1 Month Performance-14.85%3 Month Performance-31.99%6 Month Performance+42.65%Year-To-Date Performance-14.49%1 Year Performance-6.87% Receive ARCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here ARCT Stock Chart for Thursday, May, 9, 2024 ARCT Chart by TradingView Arcturus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$27.56$27.21-1.27%$27.45$26.71317,948 shs$732.71 million05/07/2024$27.32$27.56+0.88%$27.85$27.05474,271 shs$742.19 million05/06/2024$27.27$27.32+0.18%$27.90$26.72274,832 shs$735.73 million05/03/2024$26.52$27.27+2.83%$28.35$26.77671,641 shs$734.38 million05/02/2024$27.91$26.52-4.98%$28.14$26.00692,569 shs$714.18 million05/01/2024$25.57$27.91+9.15%$28.43$25.55939,753 shs$751.34 million Get the Latest News and Ratings for ARCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$26.63$25.57-3.98%$26.43$25.44584,705 shs$688.34 million04/29/2024$26.55$26.63+0.30%$27.52$26.43296,544 shs$716.88 million04/26/2024$26.17$26.55+1.45%$26.86$25.84275,687 shs$714.73 million04/25/2024$26.98$26.17-3.00%$26.80$25.41526,939 shs$704.50 million04/24/2024$27.93$26.98-3.40%$28.34$26.59266,354 shs$726.30 million04/23/2024$27.06$27.93+3.22%$28.80$27.03314,074 shs$751.88 million04/22/2024$25.98$27.06+4.16%$27.74$25.96327,983 shs$728.46 million04/19/2024$26.32$25.98-1.29%$26.88$25.57625,391 shs$699.25 million04/18/2024$27.64$26.32-4.78%$27.45$26.26607,514 shs$708.53 million04/17/2024$30.13$27.64-8.26%$30.89$27.47609,090 shs$744.07 million04/16/2024$29.31$30.13+2.80%$30.76$28.79385,057 shs$811.10 million04/15/2024$30.43$29.31-3.68%$30.68$29.12609,596 shs$789.03 million04/12/2024$32.54$30.43-6.48%$32.28$30.02405,050 shs$819.18 million04/11/2024$31.84$32.54+2.20%$33.11$31.86547,643 shs$875.98 million04/10/2024$31.66$31.84+0.57%$31.94$30.14689,564 shs$857.13 million04/09/2024$30.93$31.66+2.36%$31.71$30.31821,998 shs$852.29 million04/08/2024$31.97$30.93-3.25%$32.01$30.48392,561 shs$832.64 million04/05/2024$30.60$31.97+4.48%$32.30$30.00309,513 shs$860.63 million04/04/2024$32.74$30.60-6.54%$33.43$30.23509,853 shs$823.75 million04/03/2024$32.22$32.74+1.61%$33.33$32.09546,230 shs$881.36 million04/02/2024$33.08$32.22-2.60%$33.23$31.58379,855 shs$867.36 million04/01/2024$33.77$33.08-2.04%$33.99$32.21425,303 shs$890.51 million03/29/2024$33.77$33.77$33.84$32.00527,839 shs$909.09 million03/28/2024$32.86$33.77+2.77%$33.84$32.00527,835 shs$909.09 million03/27/2024$32.13$32.86+2.27%$33.00$31.76867,781 shs$884.59 million03/26/2024$34.79$32.13-7.65%$35.48$31.76554,647 shs$864.94 million03/25/2024$33.90$34.79+2.63%$35.68$33.71800,231 shs$936.55 million03/22/2024$33.13$33.90+2.32%$34.33$32.60326,295 shs$912.59 million03/21/2024$33.15$33.13-0.06%$34.12$32.92328,175 shs$891.86 million03/20/2024$33.76$33.15-1.81%$33.76$32.57620,766 shs$892.23 million03/19/2024$33.13$33.76+1.90%$35.02$32.52700,476 shs$908.82 million03/18/2024$36.31$33.13-8.76%$36.96$33.02586,786 shs$885.23 million03/15/2024$36.37$36.31-0.16%$37.31$36.04722,545 shs$970.31 million03/14/2024$37.90$36.37-4.04%$37.82$36.00489,872 shs$971.81 million1970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP03/13/2024$38.69$37.90-2.04%$39.58$37.67629,770 shs$1.01 billion03/12/2024$37.89$38.69+2.11%$39.55$37.66740,873 shs$1.03 billion03/11/2024$36.86$37.89+2.79%$38.98$37.01480,775 shs$1.01 billion03/08/2024$37.19$36.86-0.89%$39.70$35.06456,736 shs$984.90 million03/07/2024$37.78$37.19-1.56%$38.72$37.03523,274 shs$993.72 million03/06/2024$37.56$37.78+0.59%$38.64$37.02840,244 shs$1.01 billion03/05/2024$37.65$37.56-0.24%$38.19$37.10316,907 shs$1.00 billion03/04/2024$39.73$37.65-5.24%$40.40$37.47344,262 shs$1.01 billion03/01/2024$38.76$39.73+2.50%$40.48$38.77589,316 shs$1.06 billion02/29/2024$40.18$38.76-3.53%$41.24$38.40499,793 shs$1.04 billion02/28/2024$42.99$40.18-6.54%$42.92$40.18408,862 shs$1.07 billion02/27/2024$40.94$42.99+5.01%$43.74$41.54514,999 shs$1.15 billion02/26/2024$37.42$40.94+9.41%$41.14$37.41604,544 shs$1.09 billion02/23/2024$37.44$37.42-0.05%$38.03$37.01339,805 shs$999.86 million02/22/2024$35.28$37.44+6.12%$37.81$34.76417,261 shs$1.00 billion02/21/2024$36.21$35.28-2.57%$35.70$34.52364,134 shs$942.68 million02/20/2024$36.92$36.21-1.92%$36.98$35.69396,715 shs$967.53 million02/19/2024$36.92$36.92$37.99$36.61340,300 shs$986.50 million02/16/2024$38.19$36.92-3.33%$37.99$36.61338,770 shs$986.50 million02/15/2024$38.46$38.19-0.70%$39.10$37.69378,531 shs$1.02 billion02/14/2024$38.77$38.46-0.80%$39.83$38.16587,980 shs$1.03 billion02/13/2024$41.62$38.77-6.85%$40.21$37.20566,385 shs$1.04 billion02/12/2024$39.64$41.62+4.99%$41.68$39.63424,154 shs$1.11 billion02/09/2024$37.91$39.64+4.56%$39.88$37.40467,116 shs$1.06 billion02/08/2024$37.30$37.91+1.64%$39.00$37.67453,783 shs$1.01 billion Related Companies: Cogent Biosciences Stock Price Chart PureTech Health Stock Price Chart SIGA Technologies Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Y-mAbs Therapeutics Stock Price Chart Disc Medicine Stock Price Chart Savara Stock Price Chart Wave Life Sciences Stock Price Chart Dianthus Therapeutics Stock Price Chart Mineralys Therapeutics Stock Price Chart Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARCT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.